Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

CDSCO panel grants clearance to Morepen Labs to conduct BE studies for fatty liver disease drug

Cancer drug: AstraZeneca Pharma India bags CSDCO permission to import Lynparza

Written By Ruchika Sharma26 Nov 2024 3:54 PM IST

Bangalore: AstraZeneca Pharma India Limited has received permission to import for sale and distribution in Form CT-20 from the Central Drugs...

Natco Pharma submits application with USFDA for Risdiplam for Oral Solution

Written By Ruchika Sharma26 Nov 2024 3:21 PM IST

Hyderabad: Natco Pharma, an Indian pharmaceutical company has announced the submission of an Abbreviated New Drug Application (ANDA)...

Aarti Pharmalabs Gets Single Observation in USFDA Inspection at Tarapur Unit

Medtronic receives USFDA clearance for new InPen app featuring missed meal dose detection

Written By Ruchika Sharma26 Nov 2024 12:00 PM IST

Galway: Medtronic plc has announced U.S. Food and Drug Administration (FDA) clearance for its new InPen app featuring missed meal dose detection,...

Sun Pharma unit Taro recalls over 17k units of antifungal medication in US

Dr Reddy's Labs unit, Lupin arm recall products in US

Written By Ruchika Sharma26 Nov 2024 11:30 AM IST

Dr Reddy's Labs, Lupin are recalling products in the US, according to the US Food and Drug Administration (USFDA).A US-based unit of Dr Reddy's...

USFDA approves AbbVie giant cell arteritis drug Rinvoq in adults

AbbVie gets European Commission nod for Elahere for Platinum-Resistant ovarian cancer

Written By Ruchika Sharma19 Nov 2024 6:24 PM IST

North Chicago: AbbVie has announced the European Commission (EC) has granted marketing authorization for ELAHERE (mirvetuximab soravtansine) for...

Merck gets positive EU CHMP opinion for Keytruda plus Chemotherapy as first-line treatment for adult patients with unresectable non-eithelioid Malignant Pleural Mesothelioma

Written By Ruchika Sharma19 Nov 2024 2:30 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency's Committee for Medicinal...

Shilpa Biologicals, Stein Cares Ink Exclusive Biosimilar Licensing Pact for Latin America

Ratio enters license, collaboration agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate

Written By Ruchika Sharma19 Nov 2024 1:30 PM IST

Boston: Ratio Therapeutics Inc, has entered into an exclusive worldwide license and collaboration agreement with Novartis Pharma AG, a subsidiary...

AstraZeneca, Jacobio Pharma ink pact for proprietary Pan-KRAS inhibitor

AstraZeneca Tagrisso recommended for approval in EU by CHMP for patients with unresectable EGFR mutated lung cancer

Written By Ruchika Sharma19 Nov 2024 12:15 PM IST

Cambridge: AstraZeneca's Tagrisso (osimertinib) has been recommended for approval in the European Union (EU) for the treatment of adult patients...

Shilpa Medicare Enters US Transdermal Market, Files First ANDA for Rotigotine Patch

Shilpa Pharma Lifesciences gets CEP from EDQM for API, Octreotide

Written By Ruchika Sharma19 Nov 2024 11:19 AM IST

Karnataka: Shilpa Medicare has announced that the Company’' 100% subsidiary, Shilpa Pharma Lifesciences Limited has received a certificate of...

USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers Squibb

Bristol Myers Squibb gets positive CHMP opinion for Opdivo plus Yervoy to treat adult with MSI-H or dMMR metastatic Colorectal Cancer

Written By Ruchika Sharma18 Nov 2024 4:57 PM IST

Princeton: Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...

Cipla Recalls Cancer Drug Nilotinib in US Over Manufacturing Issue

Dr Reddy's Labs, FDC recall generic medications in US over manufacturing issues

Written By Ruchika Sharma18 Nov 2024 1:02 PM IST

New Delhi: Dr Reddy's Laboratories and FDC Ltd, are recalling generic medications in the US over manufacturing defects. According to the US Food...

Cipla, Hetero win bid to supply widely prescribed diabetes drug in China

Lucknow: Drugs worth Rs 2 crore seized from railway station

Written By Ruchika Sharma18 Nov 2024 11:00 AM IST

Lucknow: In a joint operation by the Government Railway Police (GRP) and Railway Protection Force (RPF) at the Charbagh railway station,...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok